Quest Diagnostics Declares $0.80 Dividend While Advancing Health Outcomes and Innovation
- Quest Diagnostics declares a quarterly cash dividend of $0.80 per share, payable on January 28, 2026.
- The company emphasizes its commitment to improving health outcomes through extensive diagnostic insights and data.
- Quest Diagnostics actively engages in healthcare innovation, contributing to advancements like the AD-Detect® test for Alzheimer's detection.
Quest Diagnostics Declares Quarterly Dividend Amidst Commitment to Enhancing Health Outcomes
Quest Diagnostics, a leading figure in the diagnostic information services sector, announces its Board of Directors has declared a quarterly cash dividend of $0.80 per share. This dividend is set to be disbursed on January 28, 2026, to shareholders recorded as of January 13, 2026. This financial decision reflects Quest's robust operational strength and commitment to returning value to its shareholders while simultaneously focusing on improving health outcomes through its expansive diagnostic capabilities.
The company emphasizes its role in transforming healthcare through extensive diagnostic insights derived from one of the world’s largest databases of de-identified clinical lab results. By serving one in three adult Americans and collaborating with approximately half of the physicians and hospitals in the United States, Quest Diagnostics positions itself as a vital player in the healthcare ecosystem. With over 55,000 employees, the organization is dedicated to inspiring actions that promote healthier lives, leveraging its vast repository of data to empower both individuals and healthcare providers in identifying and treating diseases more effectively.
Quest Diagnostics continues to push the boundaries of innovation within the industry, contributing to advancements like the AD-Detect® test designed for early detection of Alzheimer’s disease. This initiative underscores the company’s commitment to impactful public health solutions, supporting its mission to foster a healthier world. Additionally, Quest’s participation in forums such as Citi's 2025 Global Healthcare Conference highlights its active engagement with healthcare leaders, showcasing the latest advancements and collaborative efforts aimed at improving diagnostic services and patient care.
In tandem with its dividend announcement, Quest Diagnostics remains at the forefront of healthcare innovation, demonstrating a dual commitment to its shareholders and the communities it serves. The company invites interested stakeholders to explore more about its services and initiatives through its website, www.QuestDiagnostics.com. This blend of financial prudence and dedication to health outcomes solidifies Quest Diagnostics' role as a cornerstone of modern healthcare.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

